版本:
中国

BRIEF-Mylan launches generic reclast injection

June 2 Mylan Nv

* Mylan launches generic reclast® injection

* Announced u.s. Launch of zoledronic acid injection, 5 mg/100 ml single dose vial, a generic version of novartis' reclast® injection

* Mylan NV - received final approval from u.s. Fda for its abbreviated new drug application for zoledronic acid injection, 5 mg/100 ml single dose vial Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐